Recent advances on structure, metabolism, and function of human milk oligosaccharides

Journal of Nutrition

Volumn 136, Issue 8, 2006, Pages 2127-2130

  Bode, Lars ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; MILK OLIGOSACCHARIDE DERIVATIVE; OLIGOSACCHARIDE; STABLE ISOTOPE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; BREAST FEEDING; BREAST MILK; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CARBOHYDRATE SYNTHESIS; COW; DIET; GLYCOBIOLOGY; HUMAN; MICROARRAY ANALYSIS; NUTRIENT; PROTEIN CARBOHYDRATE INTERACTION; SCREENING TEST; SOLID PHASE SYNTHESIS;

BOS TAURUS;

EID: 33746647818     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.8.2127     Document Type: Article

References (51)

1. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20:699-722.
2. Gnoth MJ, Kunz C, Kinne-Saffran E, Rudloff S. Human milk oligosaccharides are minimally digested in vitro. J Nutr. 2000;130:3014-20.
3. Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr. 2000;71:1589-96.
4. György P, Norris RF, Rose CS. Bifidus factor I. A variant of Lactobacillus bifidus requiring a special growth factor. Arch Biochem Biophys. 1954;48:193-201.
5. Euler AR, Mitchell DK, Kline R, Pickering LK. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk. J Pediatr Gastroenterol Nutr. 2005;40:157-64.
6. Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schopfer H, Bockler HM, Wells J. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40:36-42.
7. Sharon N. Carbohydrate-lectin interactions in infectious disease. Adv Exp Med Biol. 1996;408:1-8.
8. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr. 2005;25:37-58.
9. Cravioto A, Reyes RE, Trujillo F, Uribe F, Navarro A, De La Roca JM, Hernandez JM, Perez G, Vazquez V. Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am J Epidemiol. 1990;131:886-904.
10. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem. 2003;278:14112-20.
11. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. [see comment] J Pediatr. 2004;145:297-303.
12. Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Guerrero ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS. Human milk alphal,2-linked fucosylated oligosaccharides decrease risk of diarrhea due to stable toxin of E. coli in breastfed infants. Adv Exp Med Biol. 2004;554:457-61.
13. Angeloni S, Ridet JL, Kusy N, Gao H, Crevoisier F, Guinchard S, Kochhar S, Sigrist H, Sprenger N. Glycoprofiling with micro-arrays of glycoconjugates and lectins. Glycobiology. 2005;15:31-41.
14. Vanmaele RP, Heerze LD, Armstrong GD. Role of lactosyl glycan sequences in inhibiting enteropathogenic Escherichia coli attachment. Infect Immun. 1999;67:3302-7.
15. Andersson B, Porras O, Hanson LA, Lagergard T, Svanborg-Eden C. Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. J Infect Dis. 1986;153:232-7.
16. Dewey KG, Heinig MJ, Nommsen-Rivers LA. Differences in morbidity between breast-fed and formula-fed infants. J Pediatr. 1995;126:696-702.
17. Obermeier S, Rudloff S, Pohlentz G, Lentze MJ, Kunz C. Secretion of 13C-labelled oligosaccharides into human milk and infant's urine after an oral [13C]galactose load. Isotopes Environ Health Stud. 1999;35:119-25.
18. Gnoth MJ, Rudloff S, Kunz C, Kinne RK. Investigations of the in vitro transport of human milk oligosaccharides by a Caco-2 monolayer using a novel high performance liquid chromatography-mass spectrometry technique. J Biol Chem. 2001;276:34363-70.
19. Rudloff S, Pohlentz G, Diekmann L, Egge H, Kunz C. Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula. Acta Paediatr. 1996;85:598-603.
20. Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003;9:263-8.
21. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-14.
22. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol. 1999;106:391-9.
23. Varki A. Selectin ligands: will the real ones please stand up? J Clin Invest. 1997;99:158-62.
24. Rudloff S, Stefan C, Pohlentz G, Kunz C. Detection of ligands for selectins in the oligosaccharide fraction of human milk. Eur J Nutr. 2002;41:85-92.
25. Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S. Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb Haemost. 2004;92:1402-10.
26. Maaheimo H, Renkonen R, Turunen JP, Penttila L, Renkonen O. Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin. Eur J Biochem. 1995;234:616-25.
27. Bode L, Rudloff S, Kunz C, Strobel S, Klein N. Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil beta 2 integrin expression. J Leukoc Biol. 2004;76:820-6.
28. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990;336:1519-23.
29. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol. 2003;6:6-23.
30. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med. 1998;76:402-12.
31. Crocker PR. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr Opin Struct Biol. 2002;12:609-15.
32. van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol. 2003;3:697-709.
33. Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, Pollakis G, Paxton WA. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest. 2005;115:3256-64.
34. Park Y, Lebrilla CB. Application of Fourier transform ion cyclotron resonance mass spectrometry to oligosaccharides. Mass Spectrom Rev. 2005;24:232-64.
35. Palcic MM, Zhang B, Qian X, Rempel B, Hindsgaul O. Evaluating carbohydrate-protein binding interactions using frontal affinity chromatography coupled to mass spectrometry. Methods Enzymol. 2003;362:369-76.
36. Xia B, Kawar ZS, Ju T, Alvarez RA, Sachdev GP, Cummings RD. Versatile fluorescent derivatization of glycans for glycomic analysis. Nat Methods. 2005;2:845-50.
37. Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, Bryan MC, Fazio F, Calarese D. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A. 2004;101:17033-8.
38. Plante OJ, Palmacci ER, Seeberger PH. Automated solid-phase synthesis of oligosaccharides. Science. 2001;291:1523-7.
39. Seeberger PH, Werz DB. Automated synthesis of oligosaccharides as a basis for drug discovery. Nat Rev Drug Discov. 2005;4:751-63.
40. Routenberg Love KR, Seeberger PH. Automated solid-phase synthesis of protected tumor-associated antigen and blood group determinant oligosaccharides. Angew Chem Int Ed Engl. 2004;43:602-5.
41. Kunz C, Rudloff S, Schad W, Braun D. Lactose-derived oligosaccharides in the milk of elephants: comparison with human milk. Br J Nutr. 1999;82:391-9.
42. Martinez-Ferez A, Rudloff S, Guadix A, Henkel CA, Pohlentz G, Boza JJ, Guadix Em, Kunz, C. Goat's milk as a natural source of lactose-derived oligosaccharides: isolation by membrane technology. Int Dairy J. 2006;16:174-178.
43. Ackland ML, Michalczyk A, Whitehead RH. PMC42, a novel model for the differentiated human breast. Exp Cell Res. 2001;263:14-22.
44. Prieto PA, Mukerji P, Kelder B, Erney R, Gonzalez D, Yun JS, Smith DF, Moremen KW, Nardello C. Remodeling of mouse milk glycoconjugates by transgenic expression of a human glycosyltransferase. J Biol Chem. 1995;270:29515-9.
45. Rudloff S, Obermeier S, Borsch C, Pohlentz C, Hartmann R, Brosicke H, Lentze MJ, Kunz C. Incorporation of orally applied 13C-galactose into milk lactose and oligosaccharides. Glycobiology 2006;16:478-87.
46. Irie A, Suzuki A. CMP-N-Acetylneuraminic acid hydroxylase is exclusively inactive in humans. Biochem Biophys Res Commun. 1998;248:330-3.
47. Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, Muchmore E. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A. 2003;100:12045-50.
48. Bardor M, Nguyen DH, Diaz S, Varki A. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem. 2005;280:4228-37.
49. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation. 2002;9:376-81.
50. Morito T, Nishimaki T, Masaki M, Yoshida H, Kasukawa R, Nakarai H, Hano K. Studies on Hanganutziu-Deicher antigens-antibodies. I. Hanganutziu-Deicher antibodies of IgG class in liver diseases. Int Arch Allergy Appl Immunol. 1986;81:204-8.
51. Higashihara T, Takeshima T, Anzai M, Tomioka M, Matsumoto K, Nishida K, Kitamura Y, Okinaga K, Naiki M. Survey of Hanganutziu and Deicher antibodies in operated patients. Int Arch Allergy Appl Immunol. 1991;95:231-5.